CellSource Company Description

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan.

The company provides processing services to extract adipose-derived stem cells from patients’ adipose tissues, and to prepare platelet-rich plasma from patients’ blood; and offers support services for medical facilities providing regenerative medicine therapy.

It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum.

The company was incorporated in 2015 and is headquartered in Shibuya, Japan.

CellSource Co., Ltd.

Country	Japan
Founded	2015
Industry	Biotechnology
Sector	Healthcare
Employees	157
CEO	Masayuki Yamakawa

Contact Details

Address: SHIBUYA CAST. Shibuya, 150-0002 Japan
Phone	81 3 6455 5308
Website	cellsource.co.jp

Stock Details

Ticker Symbol	4880
Exchange	Tokyo Stock Exchange
Fiscal Year	November - October
Reporting Currency	JPY
ISIN Number	JP3423580004
SIC Code	8731

Key Executives

Name	Position
Masayuki Yamakawa	Chief Executive Officer